Revision 4

#78576Store at +4C

Cell Signaling Technology

Orders: 877-616-CELL (2355) [email protected]

Support: 877-678-TECH (8324)

Web: [email protected] cellsignal.com

3 Trask LaneDanversMassachusetts01923USA
For Research Use Only. Not for Use in Diagnostic Procedures.
Applications:

IHC-Bond, IHC-P

REACTIVITY:

H

SENSITIVITY:

Endogenous

MW (kDa):

Source/Isotype:

Mouse IgG1

UniProt ID:

#P54278

Entrez-Gene Id:

5395

Product Information

Product Usage Information

Application Dilution
IHC Leica Bond 1:200 - 1:800
Immunohistochemistry (Paraffin) 1:200 - 1:800

Storage

Supplied as liquid tissue culture supernatant containing sodium azide as a preservative. Stable for 6 months when stored at 4°C. Do not aliquot the antibody.

Specificity / Sensitivity

PMS2 (M0R4G) Mouse mAb recognizes endogenous levels of PMS2 protein.

Species Reactivity:

Human

Source / Purification

Monoclonal antibody is produced by immunizing animals with a prokaryotic recombinant protein corresponding to 160 amino acids of the C–terminal region of human PMS2 protein.

Background

DNA mismatch repair (MMR), a conserved process for detecting and correcting errors made during DNA synthesis, is crucial to the maintenance of genomic integrity (1). In prokaryotes, a MutS homodimer recruits a MutL homodimer to sites of DNA mismatches. In eukaryotes, six MutS homologues (MSH1-6) and four MutL homologues (MLH1, PMS2, PMS1, and MLH3) have been identified. Heterodimers composed of two MutL homologues detect distinct DNA mismatch lesions, and heterodimers composed of two MutS homologues perform the repair (2).
Microsatellite instability (MSI) is a predisposition to genetic mutation resulting from MMR deficiency (dMMR). High MSI (MSI-H) arising from dMMR results in Lynch syndrome, also known as hereditary non-polyposis colorectal cancer (HNPCC). Lynch syndrome is associated with colon cancer, as well as other human cancers (3). MSI and dMMR are strongly associated with tumor responsiveness to immune checkpoint blockade (4,5). MSI status can be determined through PCR amplification of microsatellite markers and/or immunohistochemical detection of MMR proteins MLH1, PMS2, MSH2, and MSH6. The absence of expression of any of these MMR proteins indicates dMMR (3).

  1. Modrich, P. (2006) J Biol Chem 281, 30305-9.
  2. Kolodner, R.D. and Marsischky, G.T. (1999) Curr Opin Genet Dev 9, 89-96.
  3. Pećina-Šlaus, N. et al. (2020) Front Mol Biosci 7, 122.
  4. Kok, M. et al. (2019) ESMO Open 4, e000511.
  5. Yi, M. et al. (2018) Mol Cancer 17, 129.

Species Reactivity

Species reactivity is determined by testing in at least one approved application (e.g., western blot).

Applications Key

IHC-Bond: IHC Leica Bond IHC-P: Immunohistochemistry (Paraffin)

Cross-Reactivity Key

H: human M: mouse R: rat Hm: hamster Mk: monkey Vir: virus Mi: mink C: chicken Dm: D. melanogaster X: Xenopus Z: zebrafish B: bovine Dg: dog Pg: pig Sc: S. cerevisiae Ce: C. elegans Hr: horse GP: Guinea Pig Rab: rabbit All: all species expected

Trademarks and Patents

Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
SignalStain is a registered trademark of Cell Signaling Technology, Inc.
All other trademarks are the property of their respective owners. Visit cellsignal.com/trademarks for more information.

Limited Uses

Except as otherwise expressly agreed in a writing signed by a legally authorized representative of CST, the following terms apply to Products provided by CST, its affiliates or its distributors. Any Customer's terms and conditions that are in addition to, or different from, those contained herein, unless separately accepted in writing by a legally authorized representative of CST, are rejected and are of no force or effect.

Products are labeled with For Research Use Only or a similar labeling statement and have not been approved, cleared, or licensed by the FDA or other regulatory foreign or domestic entity, for any purpose. Customer shall not use any Product for any diagnostic or therapeutic purpose, or otherwise in any manner that conflicts with its labeling statement. Products sold or licensed by CST are provided for Customer as the end-user and solely for research and development uses. Any use of Product for diagnostic, prophylactic or therapeutic purposes, or any purchase of Product for resale (alone or as a component) or other commercial purpose, requires a separate license from CST. Customer shall (a) not sell, license, loan, donate or otherwise transfer or make available any Product to any third party, whether alone or in combination with other materials, or use the Products to manufacture any commercial products, (b) not copy, modify, reverse engineer, decompile, disassemble or otherwise attempt to discover the underlying structure or technology of the Products, or use the Products for the purpose of developing any products or services that would compete with CST products or services, (c) not alter or remove from the Products any trademarks, trade names, logos, patent or copyright notices or markings, (d) use the Products solely in accordance with CST Product Terms of Sale and any applicable documentation, and (e) comply with any license, terms of service or similar agreement with respect to any third party products or services used by Customer in connection with the Products.

Revision 4
#78576

PMS2 (M0R4G) Mouse mAb

Immunohistochemistry Image 1: PMS2 (M0R4G) Mouse mAb Expand Image
Immunohistochemical analysis of paraffin-embedded human colon carcinoma using PMS2 (M0R4G) Mouse mAb performed on the Leica® BOND Rx.
Immunohistochemistry Image 2: PMS2 (M0R4G) Mouse mAb Expand Image
Immunohistochemical analysis of paraffin-embedded human endometrioid carcinoma using PMS2 (M0R4G) Mouse mAb performed on the Leica® BOND Rx.
Immunohistochemistry Image 1: PMS2 (M0R4G) Mouse mAb Expand Image
Immunohistochemical analysis of paraffin-embedded human prostate carcinoma using PMS2 (M0R4G) Mouse mAb.
Immunohistochemistry Image 2: PMS2 (M0R4G) Mouse mAb Expand Image
Immunohistochemical analysis of paraffin-embedded human colon carcinoma using PMS2 (M0R4G) Mouse mAb.
Immunohistochemistry Image 3: PMS2 (M0R4G) Mouse mAb Expand Image
Immunohistochemical analysis of paraffin-embedded human ductal breast carcinoma using PMS2 (M0R4G) Mouse mAb.
Immunohistochemistry Image 4: PMS2 (M0R4G) Mouse mAb Expand Image
Immunohistochemical analysis of paraffin-embedded normal human thymus using PMS2 (M0R4G) Mouse mAb.
Immunohistochemistry Image 5: PMS2 (M0R4G) Mouse mAb Expand Image
Immunohistochemical analysis of paraffin-embedded normal human testis using PMS2 (M0R4G) Mouse mAb (left) compared to concentration-matched Mouse (G3A1) mAb IgG1 Isotype Control #5415 (right).
Immunohistochemistry Image 6: PMS2 (M0R4G) Mouse mAb Expand Image
Immunohistochemical analysis of paraffin-embedded KYSE-70 cell pellet (left, high-expressing) or OV-90 cell pellet (right, low-expressing) using PMS2 (M0R4G) Mouse mAb.